Search the Newsreel

Pre-market earnings update will precede Ocugen’s Aug. 6 webcast

Ocugen (NASDAQ: OCGN) has announced that it will host a conference call and live webcast on Thursday, August 6, 2026, at 8:30 a.m. ET to discuss its second-quarter 2026 financial results and provide a business update. A pre-market earnings announcement will be issued on …

Ocugen Inc Today's Market Trends | OCGN Stock Real-Time Quotes, Trading Strategies & Related Analysis | TradingKey

Ocugen Inc (OCGN) is currently trading at $1.235, having dropped 1.98% today. Its fundamentals are strong, with high growth potential, and it is considered fairly valued within the Biotechnology & Medical Research industry. Analysts have

Ocugen Inc (OCGN) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Ocugen Inc's (OCGN) dividend history and stock splits. It states that Ocugen Inc has distributed a total of $0.00 in dividends over the past five years, indicating no recent dividend payouts. The page also presents current stock data, …

Ocugen Inc (OCGN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides an incomplete revenue breakdown for Ocugen Inc (OCGN), noting that relevant data for business segments and detailed regional revenue have not yet been disclosed by the company. It does, however, list a United States revenue figure of $4.41 million with 0.00% …

Ocugen Inc. stock falls Friday, underperforms market

Ocugen Inc. (OCGN) stock experienced a 4.72% decline on Friday, closing at $1.21. This marks the seventh consecutive day of losses for the company, despite a generally favorable trading session for the broader market, with both the S&P 500 Index and Dow Jones Industrial …

Ocugen Inc (OCGN) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Ocugen Inc (OCGN), detailing its current price momentum score, support and resistance levels. It also presents an analysis of various technical indicators and moving averages, offering insights into potential trading signals for the stock. However, it emphasizes …

Ocugen Inc (OCGN) Institutional Confidence

Ocugen Inc (OCGN) has an institutional shareholding score of 3.00, placing it 192nd out of 386 in the Biotechnology & Medical Research industry. The institutional shareholding proportion has increased by 8.77% quarter-over-quarter, now standing at 24.06%. Millennium Management LLC and UBS Financial Services, Inc. …

OCGN Q2'26 Earnings: revenue estimate is 976.14K USD

Ocugen, Inc. (OCGN) is scheduled to release its Q2'26 earnings on July 31st. The company is expected to report an estimated revenue of $976.14 thousand and an EPS of ($0.05) for the quarter. This article provides a table of past and estimated revenue and …

Malvern’s Ocugen Strikes Potential $255M Gene Therapy Deal in Middle East

Malvern-based Ocugen has secured a licensing deal potentially worth up to $255 million with Kuwait’s Roots Pharmaceutical. The agreement grants exclusive rights to Ocugen's experimental blindness treatment, OCU400, across the Middle East and North Africa. OCU400 targets retinitis pigmentosa, with clinical trial results expected …

Ocugen (OCGN) Expected to Announce Earnings on Thursday

Ocugen (OCGN) targets 250M-share authorization increase tied to $130M converts

Ocugen is seeking stockholder approval to increase its authorized common stock by 250 million shares, from 390 million to 640 million, at a special meeting on September 21, 2026. This increase is intended to support future financings, mergers, collaborations, equity incentive plans, and fund …

Ocugen Inc. stock falls Monday, underperforms market

Ocugen Inc. (OCGN) stock fell 2.21% on Monday, closing at $1.33. This decline occurred during a generally down day for the stock market, with the S&P 500 Index and Dow Jones Industrial Average also experiencing losses. This marks the third consecutive day of losses …

Ocugen (OCGN) Proxy filing Summary

Ocugen (OCGN) has scheduled a Special Meeting for September 21, 2026, to vote on increasing authorized common stock and approving an adjournment if needed. The company highlights recent milestones including capital raising, debt repayment, a licensing partnership for OCU400, and progress on OCU410's Phase …

Previsión de OCGN: precio objetivo 2027, TV

Resultados financieros de Ocugen, Inc. – NASDAQ:OCGN

Análisis técnico de Ocugen, Inc. (NASDAQ:OCGN)